Southland Equity Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$514K Buy
1,418
+28
+2% +$9.59K 0.09% 164
2026
Q1
$489K Sell
1,390
-410
-23% -$146K 0.1% 152
2025
Q4
$589K Buy
1,800
+13
+0.7% +$4.12K 0.12% 126
2025
Q3
$504K Sell
1,787
-8
-0.4% -$2.32K 0.1% 140
2025
Q2
$501K Buy
1,795
+80
+5% +$22.7K 0.11% 130
2025
Q1
$534K Buy
1,715
+62
+4% +$18.3K 0.12% 115
2024
Q4
$431K Buy
1,653
+84
+5% +$24.9K 0.1% 134
2024
Q3
$506K Sell
1,569
-1
-0.1% -$327 0.12% 113
2024
Q2
$491K Buy
1,570
+11
+0.7% +$3.23K 0.14% 98
2024
Q1
$443K Buy
1,559
+21
+1% +$6.14K 0.12% 114
2023
Q4
$443K Buy
1,538
+34
+2% +$9.26K 0.14% 106
2023
Q3
$404K Buy
1,504
+188
+14% +$46.9K 0.14% 107
2023
Q2
$292K Buy
1,316
+12
+0.9% +$2.78K 0.1% 141
2023
Q1
$315K Sell
1,304
-116
-8% -$28.5K 0.12% 122
2022
Q4
$373K Buy
1,420
+426
+43% +$114K 0.14% 97
2022
Q3
$224K Sell
994
-22
-2% -$5.33K 0.11% 137
2022
Q2
$247K Buy
1,016
+44
+5% +$10.8K 0.11% 133
2022
Q1
$235K Buy
+972
New +$223K 0.1% 156
2021
Q3
Sell
-866
Closed -$211K 165
2021
Q2
$211K Buy
866
+5
+0.6% +$1.23K 0.1% 153
2021
Q1
$214K Buy
+861
New +$205K 0.12% 142

Other funds holding AMGN

Southland Equity Partners's AMGN Position: Q2 2026 in Review

Southland Equity Partners increased its Amgen (AMGN) stake by 2% in Q2 2026, buying an estimated $9.59K and bringing the position to 1,418 shares worth $514K. The position accounts for 0.09% of the portfolio, ranked #164.

Southland Equity Partners first reported a position in AMGN in Q1 2021 and has held it in 20 quarters since. The position peaked at $589K in Q4 2025. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Southland Equity Partners held 1,418 shares of Amgen worth $514K as of Q2 2026.
  • Southland Equity Partners bought 28 Amgen shares in Q2 2026, an estimated $9.59K.
  • Amgen made up 0.09% of Southland Equity Partners's portfolio in Q2 2026, its #164 holding.
  • Southland Equity Partners first reported a position in Amgen in Q1 2021 and has held it in 20 quarters since.
  • Southland Equity Partners's Amgen position peaked at $589K in Q4 2025.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Southland Equity Partners's 13F filing for Q2 2026, filed 13 Jul 2026.